Inventaire - your friends and communities are your best library - Inventaire

Short Term Virologic Efficacies of Telbivudine versus Entecavir against Hepatitis B-Related Hepatocellular Carcinoma

লেখক

Jung Hyun Kwon

Sung Won Lee

Jeong Won Jang

Kyu Won Chung

এতে প্রকাশিত: Gastroenterology research and practice

তারিখে প্রকাশিত: 2015-03-24

মূল বিষয়: ভাইরাসবিদ্যা, entecavir

Cites articles 21

তারিখ

শিরোনাম

লেখকগণ

2012-06-26

KASL Clinical Practice Guidelines: Management of chronic hepatitis B.
2011-01-01

Risk of HBV reactivation according to viral status and treatment intensity in patients with hepatocellular carcinoma

Jin-Dong Kim
2010-04-01

A 24-week, parallel-group, open-label, randomized clinical trial comparing the early antiviral efficacy of telbivudine and entecavir in the treatment of hepatitis B e antigen-positive chronic hepatitis B virus infection in adult Chinese patients

Ming-Hua Zheng, Keqing Shi
2010-10-16

Three-year efficacy and safety of tenofovir disoproxil fumarate treatment for chronic hepatitis B.

Peter Buggisch, Robert Flisiak, Patrick Marcellin, Maria Buti
2010-12-22

No resistance to tenofovir disoproxil fumarate detected after up to 144 weeks of therapy in patients monoinfected with chronic hepatitis B virus

Patrick Marcellin
2009-05-01

Long-term monitoring shows hepatitis B virus resistance to entecavir in nucleoside-naïve patients is rare through 5 years of therapy
2009-09-01

[Practice guidelines for management of hepatocellular carcinoma 2009].
2009-01-01

Nucleotide analogs for patients with HBV-related hepatocellular carcinoma increase the survival rate through improved liver function
2008-11-01

2-Year GLOBE trial results: telbivudine Is superior to lamivudine in patients with chronic hepatitis B.

Stefan Zeuzem, Yilmaz Cakaloglu, Yun-Fan Liaw
2008-08-31

Understanding the molecular basis of HBV drug resistance by molecular modeling

Chung K Chu
2008-07-24

Efficacy of lamivudine on hepatitis B viral status and liver function in patients with hepatitis B virus-related hepatocellular carcinoma
2007-05-24

Hepatitis B virus reactivation after three-dimensional conformal radiotherapy in patients with hepatitis B virus-related hepatocellular carcinoma.

Tae Hyun Kim
2006-03-01

Entecavir versus lamivudine for patients with HBeAg-negative chronic hepatitis B

Ching-Lung Lai
2006-03-01

A comparison of entecavir and lamivudine for HBeAg-positive chronic hepatitis B

Robert Gish
2005-07-18

Efficacy of lamivudine for preventing hepatocellular carcinoma in chronic hepatitis B: A multicenter retrospective study of 2795 patients

Hiromitsu Kumada, Eiji Tanaka
2004-10-01

Lamivudine for patients with chronic hepatitis B and advanced liver disease

Yun-Fan Liaw, Tawesak Tanwandee, Geoffrey Farrell
2004-03-01

Lamivudine for the prevention of hepatitis B virus reactivation in hepatitis B s-antigen seropositive cancer patients undergoing cytotoxic chemotherapy

Benny Chung-Ying Zee, Winnie Yeo, Tony Mok, Paul Kay-Sheung Chan
2003-05-01

Decompensated hepatitis B virus-related cirrhosis successfully treated with lamivudine allowing surgery for hepatocellular carcinoma
2003-05-01

Lamivudine therapy for hepatitis B virus reactivation in a patient receiving intra-arterial chemotherapy for advanced hepatocellular carcinoma
2001-01

Reactivation of viral replication after liver resection in patients infected with hepatitis B virus
1990-03-01

Primary liver cancer in Japan. Clinicopathologic features and results of surgical treatment

নিবন্ধ - wd:Q39328124

জায়ে আপনাকে স্বাগত

the library of your friends and communities

আরো জানুন

you are offline